Singua Sp. z o.o.

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Parkinson disease2 trials
• Osteoporosis1 trial

Phase

• Phase 22 trials
• Phase 31 trial

Status

• Completed2 trials
• Terminated1 trial

Lead sponsor

• Curateq Biologics Private Limited1 trial
• Integrative Research Laboratories AB1 trial
• Sun Pharma Advanced Research Company Limited1 trial

Closed trials

• Completed

  Efficacy, safety, PK, PD, and immunogenicity of BP16 in post-menopausal osteoporosis

  2023-503790-37-00· Phase 3· Curateq Biologics Private Limited· Source

• Completed

  A Clinical Study Evaluating Efficacy of Pirepemat on Falls Frequency in Patients With Parkinson's Disease (PD)

  NCT05258071· Phase 2· Integrative Research Laboratories AB· Source

• Terminated

  PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

  NCT03655236· Phase 2· Sun Pharma Advanced Research Company Limited· Source